.jpg)
US’ P&G reports 2% dip in Q3 FY25 sales, maintains growth outlook
Procter & Gamble (P&G) has reported Q3 FY25 net sales of $19.8 billion, down 2 per cent YoY, while organic sales rose 1 per cent. Diluted and core EPS grew 1 per cent to $1.54. Gross margin declined, impacted by unfavourable mix and costs. P&G forecasts flat all-in sales and 2 per cent organic sales growth for Q4, and 2-4 per cent FY25 core EPS growth.
Procter & Gamble (P&G) has reported Q3 FY25 net sales of $19.8 billion, down 2 per cent YoY, while organic sales rose 1 per cent.
Diluted and core EPS grew 1 per cent to $1.54.
Gross margin declined, impacted by unfavourable mix and costs.
P&G forecasts flat all-in sales and 2 per cent organic sales growth for Q4, and 2-4 per cent FY25 core EPS growth.
